Clinical Trial Update: Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a peripherally acting µ-opioid receptor antagonist assessing effects in recurrent acute pancreatitis across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis
• Pancreatitis Acute

Drugs mentioned

• Peripherally acting µ-opioid receptor antagonist

Snippet

Sponsor: Asbjørn Mohr Drewes | Conditions: Pancreatitis, Acute | Phase 2, Phase 3 | Status: UNKNOWN